3-iodobenzylguanidine has been researched along with nicorandil in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Ichikawa, S; Iwasaki, T; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Minami, K; Sato, Y; Sumino, H; Toyama, T | 1 |
1 trial(s) available for 3-iodobenzylguanidine and nicorandil
| Article | Year |
|---|---|
Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction.
Topics: 3-Iodobenzylguanidine; Angioplasty, Balloon, Coronary; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Infarction; Nicorandil; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2005 |
1 other study(ies) available for 3-iodobenzylguanidine and nicorandil
| Article | Year |
|---|---|
Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Adult; Aged; Aged, 80 and over; Chronic Disease; Death; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Nicorandil; Organ Size; Prognosis; Radionuclide Imaging; Sympathetic Nervous System | 2014 |